We are live on ! Find out more
RXDX

Prometheus Biosciences, Inc. Common Stock
RXDX

Delisted

RXDX was delisted on the 15th of June, 2023.

Back to rankings

2 hedge funds and large institutions have $1.98M invested in Prometheus Biosciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 216 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% less call options, than puts

Call options by funds: $13.6M | Put options by funds: $51.5M

99% less funds holding

Funds holding: 219 → 2 (-217)

100% less capital invested

Capital invested by funds: $4.35B → $1.98M (-$4.35B)

100% less funds holding in top 10

Funds holding in top 10: 13 → 0 (-13)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 216

Holders
2
Holders Change
-217
Holders Change %
-99.09%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-13
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
216
Calls
$13.6M
Puts
$51.5M
Net Calls
-$37.9M
Net Calls Change
-$118M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$351M
2
BlackRock
BlackRock
New York
-$300M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$292M
4
BC
Boxer Capital
California
-$204M
5
7IH
72 Investment Holdings
Connecticut
-$198M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
76
Two Sigma Investments
New York
– -$5.9M -54,988 Closed
TD Asset Management
77
TD Asset Management
Ontario, Canada
– -$5.75M -53,575 Closed
Axa
78
Axa
France
– -$5.54M -51,597 Closed
TCM
79
Tekla Capital Management
Massachusetts
– -$5.42M -50,538 Closed
AAM
80
AR Asset Management
California
– -$5.41M -50,414 Closed
Susquehanna International Group
81
Susquehanna International Group
Pennsylvania
– -$5.38M -50,128 Closed
Swiss National Bank
82
Swiss National Bank
Switzerland
– -$5.38M -50,100 Closed
Citadel Advisors
83
Citadel Advisors
Florida
– -$5.06M -47,146 Closed
RhumbLine Advisers
84
RhumbLine Advisers
Massachusetts
– -$5.06M -47,127 Closed
BAMCO Inc
85
BAMCO Inc
New York
– -$4.59M -42,750 Closed
Manulife (Manufacturers Life Insurance)
86
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$4.49M -41,883 Closed
AllianceBernstein
87
AllianceBernstein
Tennessee
– -$4.41M -41,100 Closed
Canada Pension Plan Investment Board
88
Canada Pension Plan Investment Board
Ontario, Canada
– -$4.4M -41,000 Closed
SEI Investments
89
SEI Investments
Pennsylvania
– -$4.1M -38,202 Closed
California Public Employees Retirement System
90
California Public Employees Retirement System
California
– -$4.01M -37,339 Closed
Barclays
91
Barclays
United Kingdom
– -$3.92M -36,510 Closed
Artisan Partners
92
Artisan Partners
Wisconsin
– -$3.71M -34,592 Closed
California State Teachers Retirement System (CalSTRS)
93
California State Teachers Retirement System (CalSTRS)
California
– -$3.58M -33,364 Closed
Wellington Management Group
94
Wellington Management Group
Massachusetts
– -$3.54M -32,976 Closed
AA
95
ALPS Advisors
Colorado
– -$3.36M -31,316 Closed
EI
96
EAM Investors
California
– -$3.24M -30,201 Closed
IHAM
97
Integral Health Asset Management
New York
– -$3.22M -30,000 Closed
TLP
98
Tri Locum Partners
New York
– -$3.06M -28,470 Closed
New York State Common Retirement Fund
99
New York State Common Retirement Fund
New York
– -$3.03M -28,231 Closed
Legal & General Group
100
Legal & General Group
United Kingdom
– -$2.96M -27,556 Closed
2 3
4
5 6

RXDX Hedge Fund Activity: Q2 2023 in Review

2 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Prometheus Biosciences, Inc. Common Stock (RXDX) for Q2 2023, worth a combined $1.98M — down 100% from $4.35B a quarter earlier.

Sellers outnumbered buyers: 216 funds closed out of RXDX and 0 opened new positions — a net loss of 216 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RTW Investments, exiting entirely with an estimated $351M sold.

  • 2 institutional investors held Prometheus Biosciences, Inc. Common Stock (RXDX) as of Q2 2023, down from 219 in Q1 2023.
  • Funds reported $1.98M of Prometheus Biosciences, Inc. Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Prometheus Biosciences, Inc. Common Stock positions in Q2 2023 and 216 closed out, a net change of -216 holders.
  • The largest Prometheus Biosciences, Inc. Common Stock seller in Q2 2023 was RTW Investments, an estimated $351M sold.

Based on aggregated 13F filings for Q2 2023.